Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
Coronaviruses ; 2(3):291-295, 2021.
Article in English | EMBASE | ID: covidwho-2286302

ABSTRACT

Background: The Coronavirus disease 2019 (COVID-19) is a transmissible illness produced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has now quickly expanded since its outbreak in Wuhan City of Hubei region of China to the other parts of the world. In accordance with the Centers for Disease Control and Prevention (CDC), the spread of COVID-19 emerges typically hu-man-to-humans through respiratory droplets within an area of 1-2 meters. Aims and Objective: In the present perspective, we have discussed some of the measures taken to pre-vent and treat the patients suffering from COVID-19, and how to restrict further spread of COVID-19 due to SARS-CoV-2. Result(s): The general clinical properties are fever, cough, sore throat, headache, tiredness, myalgia and difficulty in breathing. Presently no approved treatments for COVID-19, as of now, no pharmaceutical products have been revealed to be harmless and efficient for the management of COVID-19. Various anti-viral medicines e.g. ribavirin, lopinavir, and ritonavir have been utilized supported on the familiar-ity with SARS and MERS. Many drugs and vaccines are currently being studied in clinical trials, jointly (Solidarity trial) co-sponsored by the WHO. Conclusion(s): The use of a mask by fit people in community areas to guard against respiratory viral disease is presently recommended by WHO. Patients must be kept in individual rooms, the rooms, surfaces and equipment should go through standard sanitization, possibly with sodium hypochlorite. Conse-quently, apart from restricting this epidemic, efforts should be made to plan wide-ranging procedures to thwart potential outbreaks of the zoonotic sources.Copyright © 2021 Bentham Science Publishers.

2.
International Journal of Current Pharmaceutical Research ; 12(5):1-4, 2020.
Article in English | EMBASE | ID: covidwho-845704

ABSTRACT

The outbreak of pneumonia of unknown cause during December 2019 was reported from Wuhan City, Hubei province capital in China as its epicenter. Symptoms of pneumonia in several patients admitted to hospitals from Wuhan, China during December 2019. The sudden increase in the patients having the same symptoms, in due course the contributing means was isolated from the infected populace. In the present short report, we have summarized various public health measures, viz., early marking of the suspected patient, diagnosis, and supervision of the suspected cases that will help prevent Coronavirus disease in 2019. At the start, it was named as the 2019 novel coronavirus (2019-nCoV), and later it has been named Coronavirus disease 2019 (COVID-19) recently. Within a few weeks of a short period, the virus affected the other of China after Wuhan and later in two to three months, it is present in more than 140 countries around the globe and adding. As of 03rd August 2020, there have been 17.6 million established cases worldwide, and 680, 894 deaths have been documented, with 11,460,074 recovered. Worldwide, multiple trails are going on with the hope to find the treatment and some have positive results. On the other hand, because no vaccine is offered, the precautionary methods are the best way to fight the virus.

SELECTION OF CITATIONS
SEARCH DETAIL